Cite
Absence of pathological proof of cancer associated with improved outcomes in early stage lung cancer
MLA
Colin T. Murphy, et al. Absence of Pathological Proof of Cancer Associated with Improved Outcomes in Early Stage Lung Cancer. Apr. 2016. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....23bfe63910804ebf5487c1bb0ab2e42b&authtype=sso&custid=ns315887.
APA
Colin T. Murphy, Nicholas G. Zaorsky, Thomas M. Churilla, Joshua E. Meyer, Alan D. Haber, Mark A. Hallman, & Talha Shaikh. (2016). Absence of pathological proof of cancer associated with improved outcomes in early stage lung cancer.
Chicago
Colin T. Murphy, Nicholas G. Zaorsky, Thomas M. Churilla, Joshua E. Meyer, Alan D. Haber, Mark A. Hallman, and Talha Shaikh. 2016. “Absence of Pathological Proof of Cancer Associated with Improved Outcomes in Early Stage Lung Cancer,” April. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....23bfe63910804ebf5487c1bb0ab2e42b&authtype=sso&custid=ns315887.